Skip to content
Home/Companies/Biotech/Seaport Therapeutics
Seaport Therapeutics

Seaport Therapeutics

Biotech·United States·Active
Entry
–
Hold
–
Status
Active

Who owns Seaport Therapeutics?

Seaport Therapeutics is an American Biotech company, currently owned by General Atlantic.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
General Atlantic
Investor
General Atlantic
General Atlantic · 2020 · Growth

Key facts

HQUnited States
SectorBiotech
Websiteseaporttx.com

More from General Atlantic

Other portfolio companies in the same fund.

58.com
Active
E-commerceChina
A-Max
A-Max
Active
Business ServicesUS
Acko
Active
TMTIndia
Adagene
Active
BiotechChina
Aimbridge Hospitality
Aimbridge Hospitality
Active
Business ServicesUS
AKQA
AKQA
Active
TMTUK

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
Ariceum Therapeutics GmbH
Active
Enterprise IrelandGermany

Questions

Who owns Seaport Therapeutics?

Seaport Therapeutics is currently owned by General Atlantic, through General Atlantic.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue